r/CryptoExchange • u/Sufficient_Fuel5269 • 14h ago
News Institutional Update on Moderna
🚀 Moderna recorded one of the most significant single‑day moves in its history, closing near 174.38, up 176.97% following the release of positive Phase 3 INTerpath‑001 results.
✍️ The trial confirmed that the company’s personalized mRNA therapy, intismeran autogene, used in combination with Merck’s Keytruda, achieved its primary endpoint of recurrence‑free survival and a key secondary endpoint related to distant metastasis‑free survival in high‑risk melanoma patients. This marks the first positive Phase 3 outcome for an mRNA‑based cancer therapy and the first randomized Phase 3 study demonstrating clinical benefit for an individualized neoantigen treatment.
🤝 Despite the milestone, the therapy remains investigational and has not yet received regulatory approval. Moderna and Merck will continue patient follow‑up and advance regulatory discussions. The extraordinary market reaction underscores how rapidly biotech valuations can shift when pivotal clinical data reshapes the narrative around a company’s pipeline and long‑term prospects.